Research
Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital
Published

Liraglutide decreases postprandial fibroblast growth factor 19 and glucagon-like peptide 2, and increases postprandial cholecystokinin in individuals with obesity

Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  • A. Bronden
  • H. H. Nerild
  • C. C. Nexoe-Larsen
  • P. H. Hellmann
  • M. Baekdal
  • I. M. Gether
  • M. P. Gillum
  • Bolette Hartmann
  • L. B. Knudsen
  • L. V. Jacobsen
  • J. F. Rehfeld
  • J. J. Holst
  • T. Vilsboll
  • D. P. Sonne
  • F. K. Knop
View graph of relations
Original languageEnglish
Publication dateSep 2021
Number of pages1
Publication statusPublished - Sep 2021

ID: 68675286